City

Chongqing (1)

Condition

Hepatic Arterial Infusion Chemotherapy (2)

Transarterial Chemoembolization (2)

HCC (1)

Hepatocellular Carcinoma (1)

Pain (1)

Regorafenib (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 4 (1)

Sponsor

Peking University Cancer Hospital & Institute (1)

The Second Affiliated Hospital of Chongqing Medical University (1)

Collaborator

Intervention

ctace/deb-tace-haic (1)

esketamine (1)

regorafenib (1)

sufentanil (1)

Study Documents

Intervention Type

drug (2)

device (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

hepatic arterial infusion chemotherapy

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting

Hepatocellular Carcinoma
+3 more

Chongqing, Chongqing, China

The Second Affiliated Hospital, Chongqing Medical University

Jun 9, 2022

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1

Not yet recruiting

HCC
+3 more

Regorafenib
cTACE/DEB-TACE-HAIC

(no location specified)

Aug 28, 2021